Status:

TERMINATED

TENS and Opioid Use After Cesarean Delivery

Lead Sponsor:

Rutgers, The State University of New Jersey

Conditions:

Cesarean Section Complications

Opioid Use

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

We propose to explore the effects of Transcutaneous Electrical Nerve Stimulation (TENS) therapy in the pain management of postpartum women. A. Objectives * To determine if the addition of TENS thera...

Detailed Description

OVERVIEW. This study is a pilot randomized interventional trial. Two categories of participants will be randomly assigned to an invention or control group, using a random number generator: normal cesa...

Eligibility Criteria

Inclusion

  • Women aged between 18 and 45 years
  • Understand and be able to follow written and oral instructions in English
  • Provide written informed consent
  • History of prior opioid addiction for half of the patients.

Exclusion

  • \- History of cardiac arrhythmia or pacemaker usage

Key Trial Info

Start Date :

November 9 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2020

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT03843788

Start Date

November 9 2018

End Date

March 31 2020

Last Update

October 29 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Robert Wood Johnson University Hospital

New Brunswick, New Jersey, United States, 08901

TENS and Opioid Use After Cesarean Delivery | DecenTrialz